Bioxcel Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bioxcel Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $113k | 185k | 0.61 |
| 2024-06-30 | $171k | 134k | 1.28 |
| 2024-03-31 | $347k | 123k | 2.82 |
| 2023-12-31 | $230k | 78k | 2.95 |
| 2023-09-30 | $190k | 75k | 2.53 |
| 2023-06-30 | $515k | 77k | 6.66 |
| 2022-12-31 | $377k | 18k | 21.48 |
| 2022-09-30 | $390k | 19k | 20.83 |
| 2022-06-30 | $223k | 17k | 13.23 |
| 2022-03-31 | $289k | 14k | 21.03 |
| 2021-12-31 | $400k | 20k | 20.29 |
| 2021-09-30 | $297k | 9.8k | 30.26 |
| 2021-06-30 | $276k | 9.5k | 29.20 |
| 2021-03-31 | $543k | 13k | 43.13 |
| 2020-12-31 | $1.4M | 31k | 46.23 |
| 2020-09-30 | $521k | 12k | 42.94 |
| 2020-06-30 | $814k | 15k | 53.02 |
| 2020-03-31 | $184k | 8.2k | 22.41 |
| 2019-12-31 | $244k | 17k | 14.57 |
| 2019-09-30 | $79k | 11k | 7.06 |
| 2019-06-30 | $3.5k | 345 | 10.00 |
| 2019-03-31 | $4.0k | 400 | 10.00 |
| 2018-12-31 | $999 | 300 | 3.33 |
| 2018-09-30 | $2.0k | 300 | 6.67 |
| 2018-06-30 | $3.0k | 300 | 10.00 |